TFF Pharmaceuticals Inc (FRA:0K30) Stock News, Headlines & Updates
TFF Pharmaceuticals Inc Stock News from GuruFocus
- 1
Jun 26, 2024
TFF Pharmaceuticals Engages Outcome Capital As a Strategic Advisor for Evaluating Partnership and Licensing Opportunities
Marketwired • 6:00am
Jun 24, 2024
TFF Pharmaceuticals Provides Regulatory Update on Tacrolimus Inhalation Powder (TFF TAC) Clinical Program for the Prevention of Lung Transplant Rejection
Marketwired • 6:00am
May 23, 2024
TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing
Marketwired • 6:00am
May 20, 2024
TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing
Marketwired • 6:00am
May 15, 2024
TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection
Marketwired • 6:00am
May 14, 2024
TFF Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update
Marketwired • 4:00pm
May 01, 2024
TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering
GlobeNewswire • 5:00pm
TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering
Marketwired • 5:00pm
Apr 30, 2024
TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering
Marketwired • 7:00pm
Apr 29, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news